Procter & Gamble Health Limited (PGHL)
Healthcare | Drug Manufacturers - Specialty & Generic
₹5757.0
0.16% (₹9.0)
Market Overview
| Market Cap | 96025608192 |
| Volume | 9401 |
| 52W High | ₹5944.5 |
| 52W Low | ₹4641.15 |
Key Ratios
| P/E Ratio | 51.892914 |
| EPS | 110.94 |
| Beta | 0.367 |
| Dividend Yield | 2.79% |
Financial Performance
Revenue Growth
-0.001%
Profit Margin
0.20402001%
ROE
0.33405998%
ROA
0.21078%
Stock Analysis Score: 60/100
Growth Score: 60/100
Key Strengths:
- Excellent profit margins above 15%
- Strong ROE above 15%
- Low volatility with beta below 1
- Strong operating margins above 15%
Recommendation
Buy - The stock shows good fundamentals with some room for improvement
Detailed Analysis
Growth: -0.0% revenue growth indicates weak business expansion.
Profitability: 20.4% profit margin shows excellent operational efficiency.
Returns: ROE of 33.4% demonstrates strong return on shareholder investment.
Valuation: PE ratio of 51.9x is expensive compared to market averages.
Trading Decision Guide
- Score 80-100: Consider for long-term investment with high conviction
- Score 60-79: Suitable for medium-term investment with regular monitoring
- Score 40-59: Short-term trading opportunities, maintain strict stop-losses
- Score Below 40: High-risk trading only, thorough research essential
Risk Factors
- Market Cap: ₹9602.6Cr
- Beta: 0.37 (Market Volatility)
- 52-Week Range: ₹4641.1 - ₹5944.5
Last Updated: 2025-06-03 05:43:15